Evidence map›Paper›PMID 25161684›Full record

ArticleARYA atherosclerosis2014

Glycemic control in type 2 diabetes mellitus prevents coronary arterial wall infection.

Morteza Izadi, Mojgan Fazel, Reza Karbasi-Afshar, Seyed Hassan Saadat, Mohammad Hassan Nasseri, Nematollah Jonaidi-Jafari, Reza Ranjbar, Davood Kazemi-Saleh

Open access · greenAbstract read
In one paragraph

Article in ARYA atherosclerosis, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Genotyping and antibiotic resistance properties ofInfection and drug resistance · 2018
    Article
  5. Article
  6. Infectious and coronary artery disease.ARYA atherosclerosis · 2016
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Morteza IzadiHealth Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Mojgan FazelInternational Travel Medicine Center of Iran, Tehran, Iran.
Reza Karbasi-AfsharAtherosclerosis Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Seyed Hassan SaadatHealth Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Mohammad Hassan NasseriHealth Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Nematollah Jonaidi-JafariHealth Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Reza RanjbarMolecular Biology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Davood Kazemi-SalehHealth Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Baqiyatallah University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDiabetes mellitus (DM) is a very well-known risk factor for development of atherosclerosis, and it has been hypothesized that poor glycemic control and hyperglycemia plays a major role in this process. In the current study, we aimed to evaluate the associates of poor glycemic control in Iranian patients who have already undergone coronary artery bypass grafting (CABG), with especial focus on the inhabitation of infectious agents within the coronary arterial wall.

methodsIn January 2010, 52 consecutive patients with type 2 DM who undergone CABG at the Department of Cardiovascular Surgery of Baqiyatallah University of Medical Sciences (Tehran, Iran) were included into this cross-sectional study and biopsy specimens from their coronary plaques were taken and analyzed by polymerase chain reaction (PCR) methods for detecting Helicobacter species, cytomegalovirus (CMV) and Chlamydia pneumoniae, and their potential relation to the glycemic control status in these patients.

resultsCompared to that in diabetic patients with mean fasting blood sugar (FBS) levels FBS < 126, atherosclerotic lesions in type 2 diabetic patients with poor glycemic control (FBS > 126) were significantly more likely to be positive for CMV PCR test (41% vs. 9%, respectively; P = 0.05). In laboratorial test results, mean triglyceride level was significantly higher among patients of poor glycemic control (168 ± 89 vs. 222 ± 125 mg/dl, respectively; P = 0.033). Hypertension was also significantly more prevalent in this population (73% vs. 36%, respectively; P = 0.034).

conclusionType 2 diabetic patients with poor glycemic control can be at higher risk for developing CMV infection in their coronary arterial wall, which can promote atherosclerosis formation process in this patient population. According to the findings of this study, we recommend better control of serum glucose levels in type 2 diabetic patients to prevent formation/progression of atherosclerosis.

Indexed as

Coronary ArteryCytomegalovirusDiabetes MellitusHyperglycemiaInfection

Identifiers

PMID25161684
PMCPMC4144376
OpenAlexW1508852021

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.